Background
==========

It has long been suspected that there is an important breast cancer tumour suppressor gene on the short arm of chromosome 8, 8p, and our array CGH data suggest that it may be close to *NRG1*\[[@B1]\]. *NRG1*encodes growth factors that bind to tyrosine kinases ErbB3 and ErbB4, and can both stimulate cell proliferation and apoptosis. *NRG1*is also quite frequently broken by chromosome translocations \[[@B2]\].

Methods and results
===================

By quantitiative PCR, *NRG1*expression was repressed or abolished in many breast cancer cell lines and tumours as compared with normal breast. Methylation analysis by sequencing or pyrosequencing bisulphite-treated DNA showed striking DNA methylation at a CpG island in *NRG1*, which is correlated with an absence of *NRG1*transcripts. Treatment of cancer cell lines with 5-aza-2-deoxycytidine reactivated the expression of *NRG1*by 7 to 100 times. *NRG1*was also methylated in tumour tissue samples while it was not in uncultured normal breast epithelium. Knocking down *NRG1*expression by siRNA led to an increase in net cell proliferation.

Conclusion
==========

*NRG1*could be the 8p tumour suppressor gene. It is located in the right place. It is silenced by methylation or other mechanisms in many breast cancer cell lines and tumours. Functionally, *NRG1*expression is antiproliferative -- shown both by our siRNA experiments and older work that showed expression to be proapoptotic to breast cancer cell line MCF7 \[[@B3]\].
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